logo
Plus   Neg
Share
Email

Aviva Simplifies Into Five Divisions; To Sell Its Stake In Hong Kong JV

Aviva plc (AV.L,AV) said Wednesday that it has simplified the company into five operating divisions, and agreed to sell its stake in Hong Kong joint venture to partner Hillhouse Capital. The company also expects operating profit for 2019 to be broadly in line with its expectations.

The new operating divisions are Investments, Savings & Retirement; UK Life; General Insurance; Europe Life; and Asia Life.

The company noted that it has retained its businesses in Singapore and China.

Aviva has also agreed to sell its stake in its Hong Kong joint venture, Blue, to its partner Hillhouse Capital. It is in discussions with its partners in relation to its business in Vietnam and joint venture in Indonesia.

In 2019, the company estimates a contribution of 300 million pounds - 400 million pounds from management actions.

Meanwhile, Aviva said it is investing 1.3 billion pounds over the next three years to transform the company into a simpler, stronger and better business.

The company aims to generate 8.5 billion pounds to 9 billion pounds of cash flow between 2019 and 2022.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Global PC shipments returned to growth in the second quarter of 2020 after seeing a significant decline in the preceding first quarter due to COVID-19 related supply-chain disruptions, according to reports by two research firms. The PC market returned to growth in the quarter as production ramped up and vendors restocked their supplies to near-normal levels. The bankruptcy filing of America's oldest apparel retailer Brooks Brothers has ignited significant interest from potential buyers for the brand. WHP Global and a venture backed by Authentic Brands Group LLC and Simon Property Group, Inc., are reportedly considering bids for the retailer. WHP Global owns the ANNE KLEIN and JOSEPH ABBOUD brands. Sundial Herbal Products has recalled around 65 products, which were misbranded and currently unapproved drugs, the U.S. Food and Drug Administration said in a statement. The recall follows an order by a federal judge in June to stop distributing the company's unapproved new drugs. The affected items include herbal products and dietary supplements.
RELATED NEWS
Follow RTT